Leading Clinical Trials at Rose Cancer Center, Denver
At Sarah Cannon at Rose Cancer Center, our experienced cancer care team is constantly exploring the latest treatment options available as well as the most innovative techniques for the detection and prevention of cancer. One way to access these advancements is through clinical or research trials.
Sometimes traditional or standard therapies are not effective for more complex cancers, but that's not a reason to give up hope.
Clinical trials are research studies conducted to answer important medical and scientific questions with the ultimate hope of finding better ways to treat diseases such as cancer. Clinical trials are used to evaluate the safety and effectiveness of new or investigational drugs, combinations of new and/or existing drugs, and drug delivery methods. Access to newer treatments is offered in the hopes that they will be more effective than standard treatments and offer hope to patients who might not be responding to existing therapies.
National Leading Trial for State-of-the-Art, Efficient Breast Cancer Radiation Treatment for Early-Stage Breast Cancer
Rose Cancer Center has the leading clinical trial for Intraoperative Radiation Therapy (IORT) in the United States, led by Rose surgeon Dr. Barbara Schwartzberg.
For patients with early stage breast cancer, a lumpectomy is often included in the treatment plan, and radiation therapy goes hand-in-hand with lumpectomy. For eligible patients, IORT is an option that delivers the entire course of radiation therapy in the operating room at the time of lumpectomy and that’s it — as opposed to traditional radiation therapy where the patient goes to as many as five treatments a week for up to eight weeks. The IORT procedure allows the surgeon to remove the cancerous tumor while conserving as much of the healthy breast tissue as possible.
“IORT is a significant advancement in the treatment of breast cancer, offering women a less burdensome option to traditional radiation therapy and mitigating the arduous road to recovery many of these patients face,” said Dr. Schwartzberg. “The data presented shows positive outcomes with no recurrence of cancer, further validating the efficacy of IORT for women with early-stage breast cancer.”
Learn more about Rose’s IORT clinical trial and view a video featuring Dr. Barbara Schwartzberg explaining the procedure further.
Our Clinical Trial Partners
Rose is proud to partner with multiple leading physicians to conduct cutting edge clinical trials. The surgical team at Western Surgical Care are national leaders in the field of breast tumor treatment, including IORT as well as minimally invasive trials for benign breast tumors.
In addition, Rose Cancer Center partners with the Rocky Mountain Cancer Centers (RMCC) to offer patients access to national studies. Currently, RMCC is participating in approximately 140 clinical research trials in all major cancer types and they have nearly 30 dedicated research staff.
Sarah Cannon Research Institute
The HealthONE family of hospitals and the Sarah Cannon Cancer Network of Excellence are proud to announce the new Sarah Cannon Research Institute (SCRI) at HealthONE. Because the Rose Cancer Center is a part of the Sarah Cannon Cancer Network of excellence, our patients have access to the most advanced cancer research and clinical trial information.